Edwards Lifesciences | EW - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Abbott USD 299M 231M 2026-06
Artivion USD 5.53M 589K 2025-12
AtriCure USD 1.21M 159K 2026-03
Baxter International USD 78M 20M 2026-03
Becton, Dickinson and Co. USD 149M 4M 2026-03
Boston Scientific USD 96M 6M 2026-06
Cooper Companies USD 20.9M 1.5M 2026-03
Dexcom USD 3.1M 1.1M 2026-03
Edwards Lifesciences USD 30M 5.9M 2026-06
Globus Medical USD 5.44B 5.44B 2026-03
ICU Medical USD 20.64M 21.39M 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 11M 3.7M 2026-06
Integra LifeSciences USD 22.99M 529K 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 43M 25M 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 12.12M 5.59M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 1.15B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
Zimmer Biomet Holdings USD 22.8B 22.73B 2026-06